Thursday, June 14, 2018

Giveaway: Safer Pain Relief

The summer is coming and the warmer weather mean some people are working out harder than in the winter or trying new sports for the first time. Getting fit sometimes results in aches and pains and reaching for OTC pills is not always the healthiest solution. Doctors agree that topical OTC analgesic products, in the form of creams, gels, sprays and patches, are a healthier solution for pain management.  

“Acetaminophen has a narrow therapeutic window, meaning the difference between a safe and effective dose and an overdose, which could led to liver toxicity, is a relatively small increment in milligram consumption,” says Dr. Aristotle Economou, author and acclaimed Beverly Hills physician. “Topical pain relievers such as creams, gels and sprays work locally and large reduce, although they do not entirely eliminate the systemic risk, that OTC pain pills can present. The Salonpas Pain Relief Patch is the first and only topical non-steroidal anti-inflammatories (NSADs) approved through the FDA’s rigorous New Drug Application process which is the same process used to approve prescription medicines."

By putting the medicine right at the site of pain, bypassing the stomach and liver, Salonpas can use less medicine to deliver an effective dose.

You can receive a free sample of the SALONPAS® Pain Relieving Patch online! Please visit www.salonpassamples.com to register for your sample. Hurry...as free samples only available while supplies last!

I also have a chance to giveaway a Salonpas bundle (pictured at right). To enter, leave a comment with your biggest injury risk! Deadline is June 22nd.

The full product suite from Salonpas, www.salonpas.us includes the Salonpas® Lidocaine Plus Pain Relieving Cream, Salonpas® Lidocaine Plus Pain Relieving Liquid, Salonpas® Lidocaine Pain Relieving Gel-Patch, Salonpas® Pain Relieving Patch, Salonpas®  DEEP Relieving Gel, Salonpas® Pain Relief Patch, Salonpas®  Pain Relieving Gel-Patch Hot, and Salonpas® Pain Relieving Jet Spray.

No comments:

Post a Comment